UPDATE IN GENERAL

CARDIOLOGY

FULL C3 CONFERENCE: JUNE 23-26, 2019HILTON BONNET CREEK • ORLANDO, FLORIDA

WWW.C3CONFERENCE.NET

COMPLEX CARDIOVASCULAR CATHETER THERAPEUTICS

JUNE 23-25, 2019

Peter Libby, MD Brigham and Women’s Hospital/Harvard Medical SchoolBoston, MA Chair, General Cardiology Program

Rajesh Dave, MD, FSCAI, FACC The Ortenzio Heart Center at Holy Spirit Hospital Camp Hill, PA Chairman, C3 Global Conference

Dear Colleagues,

Welcome to the 2019 Update in General Cardiology during the C3 Conference in Orlando, Florida.

We are fortunate to witness rapid advances in cardiovascular science that add new options to us for the clinical management of our patients. While this progress is exciting, it also presents a challenge to practitioners. How do we keep up with the plethora of new information? How do we sort the wheat from the chaff? How do we judge what new studies and therapeutic options are applicable to our patients as we encounter them in our daily practice? How do we make the difficult choices about integrating novel therapies with the tried and true?

The burgeoning general cardiovascular program within the C3 Symposium aims to provide guidance to the practitioner regard these points. Expert speakers, all of whom practice clinical cardiology as well as engage in forefront research, distill the essence of the rapidly expanding knowledge base and provide a seasoned perspective on how to integrate this information into practice. Discussion among the experts airs the controversies and strengths and weaknesses regarding late-breaking clinical trials.

Where do we stand with aspirin in primary prevention in 2019? Are omega-3 fatty acids right for some of our patients? Who benefits from low dose oral anticoagulants? What is the latest information about how we can forestall re-admissions for heart failure? Whom should we refer for mitral valve intervention, what kind, and when?

Together we weigh the pros and cons of emerging therapeutic options. Using a case-based approach we put the research information into a practical context. The assembled experts interact with the attendees to elicit their insightful questions and to share best practices. We have worked hard to put together a program that will prove informative as well as exciting and invite you to join us in Orlando in June.

Thank you for your participation in this year’s Update in General Cardiology at C3. Enjoy the program!

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, is Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and Professor of Medicine at Harvard Medical School. Dr. Bhatt has been listed in Best Doctors in America from 2005 to 2018. He was selected by Brigham and

Women’s Hospital as the 2014 Eugene Braunwald Scholar. He has over 1,100 publications and is listed as a Thomson Reuters Highly Cited Researcher. He is Editor of Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease.

Dr. Bhatt obtained his undergraduate science degree as a National Merit Scholar at the Massachusetts Institute of Technology. He received his medical doctorate from Cornell University. He completed a Master in Public Health with a concentration in clinical effectiveness at Harvard University. His residency in internal medicine was performed at the Hospital of the University of Pennsylvania, and his cardiovascular training was at Cleveland Clinic.

Keynote Speaker

Faculty ListingINVITED FACULTY

Samuel Asirvatham, MDMayo Clinic Rochester, MN

Karim Al-Azizi, MDBaylor Scott & White The Heart Hospital – Plano Plano, TX

Steven Bailey, MD, MSCAIUT Health San Antonio San Antonio, TX

Sripal Bangalore, MD, MHANYU Langone Health New York, NY

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESCBrigham and Women’s Hospital/Harvard Medical SchoolNewton, MA

Wendy Bottinor, MDUniversity of Louisville Hospital Louisville, KY

Marc Bonaca, MD, MPHUniversity of Colorado School of MedicineAurora, CO

Alan Brown, MDAdvocate Good Samaritan Hospital & Advocate Lutheran General HospitalNaperville, IL

John Cahill, MD, FACCEast Carolina Heart Institute at ECUGreenville, NC

Blasé Carabello, MDEast Carolina Heart Institute at ECUGreenville, NC

Teresa Carman, MDUniversity Hospitals Cleveland Medical CenterCleveland, OH

V. Chockalingam, MD, DNBMGR Medical University Chennai, India

Ramesh Daggubati, MD, FACC, FSCAINYU Winthrop HospitalMineola, NY

Steven Dean, DO, FSVM, RPVIThe Ohio State University Wexner Medical CenterColumbus, OH

Prakash Deedwania, FACC, FAHA, FESCUCSF School of Medicine/UCSF FresnoFresno, CA

Nihar Desai, MD, MPHYale School of MedicineShelton, CT

T.S. Dharmarajan, MD, MACP, FRCPEMontefiore Medical Center Wakefield DivisionScarsdale, NY

Parag Doshi, MD, FSCAIChicago Cardiology InstituteSchaumburg, IL

Christian Erbel, MDUniversity Hospital HeidelbergHeidelberg, Germany

Michael Ezekowitz, MBChB, DPhilThe Lankenau Institute for Medical Research Villanova, PA

James Fang, MDUniversity of UtahSalt Lake City, UT

Sergio Fazio, MD, PhDOregon Health & Science UniversityPortland, OR

Joel Fuhrman, MDNutritional Research FoundationFlemington, NJ

Marie Gerhard-Herman, MDBrigham and Women’s Hospital/Harvard Medical SchoolBoston, MA

C. Michael Gibson, MD, FSCAIBaim Institute for Clinical ResearchBoston, MA

Roberto Giraldez, MD, PhDUniversity of São Paulo School of MedicineSão Paulo, Brazil

David Holmes, Jr., MDMayo ClinicRochester, MN

Daniella Kadian-Dodov, MDIcahan School of Medicine Mount Sinai, NY

Dinesh Kalra, MD, FACCRush University Medical CenterChicago, IL

Darshak Karia, MDUniversity HospitalAugusta, GA

Stuart Katz, MDNYU Langone HealthNew York, NY

Spencer King, MD, MACC, FSCAIEmory University School of MedicineAtlanta, GA

Kousik Krishnan, MDRush University Medical CenterChicago, IL

Peter Libby, MDBrigham and Women’s Hospital/Harvard Medical SchoolBoston, MA

Joe Lau, MD, PhDNorthwell Health Queens, NY

Renato Lopes, MD, PhDDuke UniversityDurham, NC

Konstantinos Marmagkiolis, MD, FSCAIFlorida Hospital Tampa & Pepin Heart InstituteWesley Chapel, FL

Matthew Martinez, MDLehigh Valley Health NetworkAllentown, PA

Darren McGuire, MD, MHScUniversity of Texas Southwestern Medical CenterDallas, TX

Kalgi Modi, MD, FSCAI, FACCLouisiana State University Shreveport, LA

Sandeep Nathan, MD, MScUniversity of Chicago Medical CenterChicago, IL

Carl Orringer, MDUniversity of Miami Health SystemPlantation, FL

Naushira Pandya, MD, FACPNova Southeastern University College of Osteopathic MedicinePlantation, FL

Purvi Parwani, MDLoma Linda University Health Loma Linda, CA

Meenakshi Patel, MDWright State University & Valley Medical Primary CareDayton, OH

Carl J. Pepine, MD, MACCUniversity of Florida Gainesville, FL

Gregory Piazza, MD, MSBrigham and Women’s Hospital/Harvard Medical SchoolWellesley, MA

Sean Pokorney, MD, MBADuke UniversityRaleigh, NC

Koushik Reddy, MDJames A. Haley VA Medical CanterTampa, FL

Faculty ListingJennifer Robinson, MDThe University of Iowa Iowa City, IA

Vivian Rocha, MDIbmec Business School Rio de Janeiro, Brazil

Christian Ruff, MD, MPHBrigham and Women’s Hospital & TIMI Study GroupBoston, MA

Rajesh Sachdeva, MDMorehouse School of MedicineAtlanta, GA

Robert Safian, MD, FSCAIBeaumont HealthRoyal Oak, MI

Aditya Sharma, MBBSUniversity of VirginiaCharlottesville, VA

Parikshit Sharma, MD, MPHRush University Medical CenterChicago, IL

Holger Thiele, MDLeipzig University HospitalLeipzig, Germany

Mintu Turakhia, MD, MASStanford Health CareStanford, CA

Tudor Vagaonescu, MD, FSCAIRutgers RWJ University HospitalNew Brunswick, NJ

Anthony Venbrux, MDThe George Washington University Medical CenterWashington, District of Columbia

George Vetrovec, MD, MACC, MSCAIVirginia Commonwealth UniversityRichmond, VA

Mary Norine Walsh, MD, FACCSt. Vincent Medical Group – Indianapolis Indianapolis, IN

Paul Whelton, MD, MScTulane UniversityNew Orleans, LA

David Wood, MD, FRCPCUniversity of British ColumbiaVancouver, Canada

Roman Zeltser, MD, FACCNassau University Medical Center & Zucker School of Medicine at Hofstra/Northwell Syosset, NY

ACCREDITATION STATEMENT

The Academy for Continued Healthcare Learning is accredited

by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

This activity is approved for AMA PRA Category 1 Credits™.

FUNDING

C3 2019 is funded by educational grants from various commercial organizations, which have no control over program content. Please visit www.c3conference.net

for a list of commercial supporters and contributors from the 2018 conference. A final list will be available onsite.

DISCLOSURE INFORMATION

Current guidelines require that participants in CME/CE activities be made aware of all affiliations or financial interests that may be perceived as affecting the presentation of the faculty member. ACHL ensures that all faculty and staff involved in the planning, development, and implementation of ACHL activities disclose all potential conflicts of interest and resolve them before the CME/CE activity occurs. Complete information will be provided to participants prior to the start of the educational activity.

CME Information

FOR ADDITIONAL CONTINUING MEDICAL EDUCATION CREDITS OFFERED, PLEASE

VISIT WWW.C3CONFERENCE.NET

ScheduleSunday, June 23, 2019NOAC in Stroke Prevention for NVAF Chair: Christian Ruff, MD, MPH Co-Chairs: Michael Ezekowitz, MBChB, DPhil, Renato Lopes, MD, PhD,

Sean Pokorney, MD, MBA

• Welcome and Introduction ��������������������������������Christian Ruff, MD, MPH

• AF Guideline Update: What Does Every Clinician Need to Know? ������������������������Christian Ruff, MD, MPH

• Screening for AF: Should We Be Doing It and How? ���������������� Michael Ezekowitz, MBChB, DPhil

• Subclinical AF: How Much AF is Enough to Warrant Anticoagulation? �������������������������� Sean Pokorney, MD, MBA

• Is There a Role for Biomarkers in Risk Stratification for AF? �����������������������������Christian Ruff, MD, MPH

• Can We Use NOACs in ESRD? ��������� Michael Ezekowitz, MBChB, DPhil

• What is the Optimal Combination Therapy in Patients with AF + CAD? ������������������������������� Renato Lopes, MD, PhD

League of Luminaries and Keynote Lecture Chairs: Ramesh Daggubati, MD, FACC, FSCAI, Alan Brown, MD,

Rajesh Dave, MD, Nihar Desai, MD, MPH, Peter Libby, MD, Christian Ruff, MD, MPH

• Introduction of Keynote Speaker and Award Distribution – Deepak L� Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC ������ Ramesh Daggubati, MD, FACC, FSCAI

• Residual Cardiovascular Risk in Statin-Treated Patients with Elevated Triglycerides: Now We Can REDUCE-IT! ��� Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

New Hopes for Heart Failure Management Chairs: Mary Norine Walsh, MD, FACC, Stuart Katz, MD, James Fang, MD Co-Chairs: Nihar Desai, MD, Rajesh Sachdeva, MD

• HFrEF vs HFpEF: What’s in a Name? ���������������������������James Fang, MD

• Managing Heart Failure with Preserved Ejection Fraction ������������������ Mary Norine Walsh, MD, FACC

• Management of Heart Failure with Reduced Ejection Fraction: Insights from SHIFT, PARADIGM HF and Others ����������������������� Stuart Katz, MD

• Practical Strategies for Reducing HF Readmissions ��������������������������������������������James Fang, MD

• What Is in the Future Pipeline of HF Therapy? ������������������������� Mary Norine Walsh, MD, FACC

• Interventional Options in the RefractoryHeart Failure: Identifying Right Patientand Choosing the Right Device ����������������������������������Darshak Karia, MD

Optimizing Clinical Outcomes by Optimizing the Management of Hyperlipidemia (Sponsored by Ciné-Med, Inc) (Supported by Independent Educational Grant from Amgen) (CME)Chairs: Alan Brown, MD, Jennifer Robinson, MD

• Welcome and Opening Remarks������������������������������������Alan Brown, MD

• LDL-C, Cardiovascular Outcomes, andResidual Risk: The Past and The Present ����������Sergio Fazio, MD, PhD

• The Discovery of PCKS9 andthe Development of PCSK9 Inhibitors ����������������������� Carl Orringer, MD

• The Impact of Evolocumab on Coronary Atherosclerosis, ClinicalOutcomes, and Neurocognitive Function: The GLAGOV, FOURIER,and EBBINGHAUS Trials ���������������������������������������Jennifer Robinson, MD

• Panel Discussion

• Clinical Case Presentations to HighlightRecent ACC/AHA Guidelines and Populationsof Special Interest for PCSK9 Inhibition������ Sean Pokorney, MD, MBA

• Case 1: A 68-Year-Old Male with Inferior Wall STEMI2 Years Ago and NSTEMI 1 Year Ago, LDL of 110mg/dLDespite Atorvastatin 80mg Daily ��������������������������Nihar Desai, MD, MPH

• Case 2: A 74-Year-Old Female with Peripheral ArteryDisease and Non-Insulin Dependent Diabetes Who HasLDL-C of 100mg/dL on Maximally Tolerated Statin(Rosuvastatin 10mg Daily) ������������������������������������������������Alan Brown, MD

• Panel Discussion with Audience Q&A

• Wrap-Up/Adjourn ���������������������������������������������������Sergio Fazio, MD, PhD

Hyperlipidemia (In Partnership with the National Lipid Association) Chairs: Alan Brown, MD, Sergio Fazio, MD, PhD Co-Chairs: Jennifer Robinson, MD, Carl Orringer, MD,

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

• The 2018 ACC/AHA/NLA CholesterolGuideline: What has Changed? ����������������������������������� Carl Orringer, MD

• Cost Effectiveness of PCSK9 Inhibitorsin the Era of Price Reduction ������������������������������Jennifer Robinson, MD

• Common Genetic Lipid Disorders thatare Uncommonly Diagnosed: Part 1Familial Hypercholesterolemia ���������������������������������������Alan Brown, MD

• Common Genetic Lipid Disorders thatare Uncommonly Diagnosed: Part 2 Lp(a) �������Sergio Fazio, MD, PhD

• The REDUCE IT Trial of EPA:Implicationsfor Practice ���� Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

• Summary and Insights of the Session ��������������������������������������All faculty

ScheduleAntithrombotics in Treatment of CAD and PAD Chair: C. Michael Gibson, MD, FSCAICo-Chairs: Marc Bonaca, MD, MPH, Marie Gerhard-Herman, MD,

Roberto Giraldez, MD, PhD

• What is the Role of NOACs in Patients with CAD Alone: Is ASA + Low Dose Rivaroxaban Really Better than DAPT? ���� Roberto Giraldez, MD, PhD

• What is the Optimal Antithrombotic Therapy in Patients with Both CAD + PAD? �� Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

• What is the Optimal Antithrombotic Therapy in Patients with PAD Alone? ������Marie Gerhard-Herman, MD

• How Do We Risk Stratify Patients with PAD: Which Patients Benefit from Intensification of Antithrombotic Therapy? �������������������������������Marc Bonaca, MD, MPH

• What is the Optimal Antithrombotic Therapy to Prevent Stroke? ������������������������������������������������������������������ TBA

• What is the Future of Antithrombotic Therapy: Emerging Therapies and Trials? ������������C. Michael Gibson, MD, FSCAI

Medical Management in Cardiology and Primary Care Chairs: Ramesh Daggubati, MD, FACC, FSCAI, Matthew Martinez, MD,

Christian Erbel, MD

• Pregnancy: Evaluation of Common Cardiac Issues ������������������������Kalgi Modi, MD, FSCAI, FACCD

• Athlete Evaluation in Cardiology: What is a Must? ��������������������������������������������������������Mathew Martinez, MD

• How to Evaluate and Manage Frequent PVC’s and PAC’s ������������������������������ Sean Pokorney, MD, MBA

• Evaluation of Patient with Leg Edema ��������������������������������������� Steven Dean, DO, FSVM, RPVI

Monday, June 24, 2019NOAC in DVT and PE Chairs: Gregory Piazza, MD, MS, Anthony Venbrux, MD, Teresa Carmen, MD

• How Long Should We Anticoagulate Patients with VTE and with What Dose? ���������������������������������������������Joe Lau, MD

• When Do Patients Need Advanced Therapies Beyond Anticoagulation with NOACs? �����������Gregory Piazza, MD, MS

• Should We Be Using IVC Filters Anymore? ������Anthony Venbrux, MD

• Should Be Using NOACs or LMWH in Cancer-Associated VTE? ���������������������������������������Teresa Carman, MD

Evolving Role of Cardiovascular Outcomes on Diabetic Management: When and How You Start New Drugs Chairs: Prakash Deedwania, FACC, FAHA, FESC, Darren McGuire, MD, MHSc,

John Stafford, MD, PhDModerator: Nihar Desai, MD

• Recent Data on CV Outcomes and Novel Diabetes Medications �����������Prakash Deedwania, FACC, FAHA, FESC

• Review of Updated ADA/ACE/AHA/ACC Guidelines on the Management of Patients with Cardiovascular Disease and Diabetes ������������������������������������Darren McGuire, MD, MHSc

• Practical Steps for Getting Started: How to Initiate Newer Diabetes Medications for Your Patients with Cardiovascular Disease ��������������������������� Nihar Desai, MD

• The Next Frontier: Future Directions for Novel Diabetes Medications, Focus on Heart Failure ����������������������������������������������Darren McGuire, MD, MHSc

Trending Cardiovascular Nutrition and Lifestyles Controversies Moderators: V. Chockalingam, MD, Ramesh Daggubati, MD, FACC, FSCAI,

Koushik Reddy, MD, Co-Moderators: Sripal Banagalore, MD, MHA, Parag Doshi, MD, FSCAI

• Weight Reduction Strategies for Resolving Emotional and Addictive Overeating �����������������������Joel Fuhrman, MD

• Mind Your Heart ��������������������������������������������������������V. Chockalingam, MD

• Heart to Heart: Conversations with a Cardiologist ������������������������������������������������������Koushik Reddy, MD

Other Issues in General Medicine Moderators: T.S.Dharmarajan, MD, MACP, FRCPE, Meenakshi Patel, MD,

Naushira Pandya, MD, FACP

• Vitamin D and Supplements���������������������� Naushira Pandya, MD, FACP

• Hyponatremia in Heart Failure �������������������������������Meenakshi Patel, MD

• Hypertension Management In Elderly ����������������� T.S.Dharmarajan, MD

Update on Hypertension Treatment 2019 Chairs: Sripal Bangalore, MD, Carl J. Pepine, MD, Paul Whelton, MD, MScCo-Moderators: Tudor Vagaonescu, MD, FSCAI

• What’s the Latest in the ACC/AHA BP Guidelines? �����������������������������������Paul Whelton, MD, MSc

• Resistant Hypertension: 2019 Update ��������������������� .Carl J. Pepine, MD

• Renal Denervation for Resistant Hypertension: Is it Dead? �����������������������������Sripal Bangalore, MD, MHA

Clinical Issues in General Cardiology Moderators: Blasé Carabello, MD, Steven Bailey, MD, David Holmes, MD

• How to Evaluate and Provide Recommendations for Low Gradient, Low Output, and Normal Output Aortic Stenosis ����������������������������������������������Blasé Carabello, MD

• Evaluation and Treatment Strategies in Patient with Severe MR and/or TR �������������������������Steven Bailey, MD

• Newer Treatment Modalities in Treatment of MR and TR �������������������������������������������Holger Thiele, MD

• Current State of PFO and Stroke: What Are the Latest Recommendations? ���� Konstantinos Marmagkiolis, MD, FSCAI

• The Latest Clinical Trials of TAVR vs SAVR: The Essentials ����������������������� David Wood, MD, FRCPC

• Primer on Evaluating Patients with PAD ����������� Aditya Sharma, MBBS

• LAA Occluder in Atrial Fibrillation: Which Patient Should be Selected Based on Evidence? �����������������David Holmes, MD

C3 Keynote Address and 15th Anniversary Celebration in Coronary Track Theater

Tuesday, June 25, 2019Coronary Artery Disease: Diagnosis and Risk Stratification Chairs: George Vetrovec, MD, MACC, MSCAI, Spencer King, MD, MACC, FSCAI,

• How Do You Risk Stratify a Patient Who Presents with Chest Pain? ���������������������������John Cahill, MD, FACC

• What Is the Role of Calcium Scoring in 2018? ���������������������������������������������������Dinesh Kalra, MD, FACC

Debate: Diagnosis of CAD

• Coronary CTA Is the New Default Strategy ������������������������������������������������Robert Safian, MD, FSCAI

• Coronary Angiography Remains the Gold Standard ����������������������� George Vetrovec, MD, MACC, MSCAI

• Rebuttal ���������������������������������������������������������������Robert Safian, MD, FSCAI

• Rebuttal ������������������������������������������ George Vetrovec, MD, MACC, MSCAI

• What Constitutes Optimal Medical Therapy in Stable Angina? �������������������������������������������������������������������� TBA

• In Which Patients PCI is Still the Preferred Mode in Patients with Stable Angina? �������Spencer King, MD, MACC, FSCAI

• Preoperative Cardiac Risk Stratification Prior to Noncardiac Surgery: Essentials �������������������� Ramesh Daggubati, MD, FACC, FSCAI

Schedule

TO VIEW THE MOST UP-TO-DATE AGENDA, VISIT WWW.C3CONFERENCE.NET

#C32019 #C3CARDIOLOGY

Atrial Fibrillation: What’s New in 2019? Chairs: Samuel Asirvatham, MD, Dinesh Kalra, MD, FACC,

Mintu Turakhia, MD, MAS

• Rhythm vs Rate Control: When to Referfor Ablation - Fallout from CABANA ��������������Samuel Asirvatham, MD

• Which Drug Cocktail and NOAC for my Patient?Overview of US and ESC Guidelines ��������� Roberto Giraldez, MD, PhD

• Is AF a Metabolic Disease? Recent Data onLifestyle and Weight Loss to Manage AF ������������Kousik Krishnan, MD

• AF in Heart Failure:A Different Approach �����������������������������������Parikshit Sharma, MD, MPH

• AF in Special Circumstances: HCM, Sleep Apnea,Thyroid Disease, Obesity, and Post-Surgical ��������Sean Pokorney, MD

• Wearable Devices and Digital Health in ArrythmiaManagement: Where are we going? �������������Mintu Turakhia, MD, MAS

• New Energy Sourcesfor Arrythmia Ablation ���������������������������������������Samuel Asirvatham, MD

Trends in Cardiology Moderators: Roman Zeltser, MD, FACC, George Vetrovec, MD, MACC, MSCAI,

Sandeep Nathan, MD, MSc

• Aspirin in Primary and Secondary CardiovascularDisease Prevention: Give, Not Give, Dosage,and Coatings �������������������������������������������������������������������� Vivian Rocha, MD

• Confronting Cardio-Oncology:An Emerging Epidemic������������������������������������������������������� Olivia Hung, MD

• Cardiovascular Risk of Recreational andAddictive Drugs Including Cocaine, Marijuana,and Opioids ������������������������������������������������������� Roman Zeltser, MD, FACC

• Artificial Intelligence Cardiology:Early Use and a Look to the Future ���������������Mintu Turakhia, MD, MAS

• Should the Physician Engage in Social Media?How to Start Off, Patient Expectations, andPotential Landmines ����������������������������������������������������� Purvi Prawani, MD

Registration

ConferenceRegistration Fees

Before May 1, 2019 After May 1, 2019

Full Conference: Industry $650 $1,195

Full Conference: Nurse/Technologist/Allied Health/Fellow/Resident/ Student

$195 $375

Podiatrist: Wound Care Program $425 $495

Full Conference: Physician $495 $895

Registration is open for the 15th Annual Complex Cardiovascular Catheter Therapeutics: Advanced Endovascular and Coronary Intervention Global Summit (C3)!

If you are paying by credit card: Visit www.c3conference.net and select “Register”. If you are paying by check: Mail check and your name/phone/email to the below address. Checks should be payable to ACHL/C3.

Mail checks to: 230 W Monroe Street, Suite 2300, Chicago, IL 60606

You will be sent a code that allows you to register each person in your group through the conference website.

Hotel InformationHilton Bonnet Creek

14100 Bonnet Creek Resort Lane Orlando, FL 32821

(407) 597-3600 www.hiltonbonnetcreek.com

Visit www.c3conference.net/Location to book your hotel room though the C3 Discounted Room Block Portal

Experience More at C3 2019

The Best Live Demonstration Course in 2019 Renowned experts from globally-reputed medical centers will perform live cases.

Partnership Sessions Highlight the Latest Clinical Challenges, organized by global interventional societies & clubs from Europe, Japan, China, Vietnam, Egypt, Thailand, Malaysia, Taiwan, Bangladesh, Pakistan, and South America.

Master Mentorship If you are a Fellow & submit challenging cases or abstracts, the Top 3 will be selected by the C3 Scientific Committee and will have an opportunity to sit one-on-one with a Legend to review your presentation and gain insights and skills on presenting.

Challenging Case & Abstract Competition Sessions Competition sessions for accepted abstract and case with the expert’s focus review. The top scientific case and abstract winner will get a $500 prize certificate!

Global Women Cardiac & Vascular Interventional Forum For the third year in a row, C3 celebrates the contributions that women make to cardiovascular medicine. We are hosting two special sessions focused on women. The TOP TEN selected and accepted cases and scientific abstracts submitted by women will be featured in these sessions.

Science & Late-Breaking Research The most influential & cutting-edge cardiovascular research for 2018-2019 will be presented with opportunity to simultaneously publish this research in leading journals.

© 2

019

Aca

dem

y fo

r C

ont

inue

d H

ealt

hcar

e Le

arni

ngC

319

0

PRSR

T ST

DU

.S. P

OST

AGE

PAID

HA

RRIS

BURG

PA

PERM

IT N

O. 5

33

Reg

istr

atio

n is

op

en f

or

the

15th A

nn

iver

sary

o

f th

e C

om

ple

x C

ard

iova

scu

lar

Cat

het

er

Th

erap

euti

cs: A

dva

nce

d E

nd

ova

scu

lar

and

C

oro

nar

y In

terv

enti

on

Glo

bal

Su

mm

it (

C3 )

C3

cele

bra

tes

its’

15th

yea

r an

niv

ersa

ry t

his

Ju

ne

23-2

6, 2

019

in O

rlan

do

, Flo

rid

a at

th

e H

ilto

n B

on

net

Cre

ek. W

e h

op

e yo

u, y

ou

r fe

llow

co

lleag

ues

, an

d f

rien

ds

will

join

us

to s

har

e an

d le

arn

in t

his

dyn

amic

ed

uca

tio

nal

op

po

rtu

nit

y!

reg

iste

r to

day

! WW

W.C

3CO

NF

ER

EN

CE

.NE

T

#C

320

19 #

C3C

ard

iolo

gy

UP

DA

TE

IN G

EN

ER

AL

CA

RD

IOLO

GY